Antidiabetic treatment patterns and specialty care utilization among patients with type 2 diabetes and cardiovascular disease

被引：0
|
作者：
Kevin M. Pantalone
Anita D. Misra-Hebert
Todd M. Hobbs
Xinge Ji
Sheldon X. Kong
Alex Milinovich
Wayne Weng
Janine Bauman
Rahul Ganguly
Bartolome Burguera
Michael W. Kattan
Robert S. Zimmerman
机构：
[1] Cleveland Clinic,Department of Endocrinology, Endocrinology and Metabolism Institute
[2] Cleveland Clinic,Medicine Institute
[3] Cleveland Clinic,Quantitative Health Sciences
[4] Novo Nordisk Inc.,Bariatric and Metabolic Institute
[5] Health Economics and Outcomes Research,undefined
[6] Novo Nordisk Inc.,undefined
[7] Cleveland Clinic,undefined
来源：
Cardiovascular Diabetology | / 17卷
关键词：
Cardiovascular disease; Type 2 diabetes; Population health; Antidiabetic therapies;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
    Nathan, DM
    Cleary, PA
    Backlund, JYC
    Genuth, SM
    Lachin, JM
    Orchard, TJ
    Raskin, P
    Zinman, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (25): : 2643 - 2653
  • [32] Dapagliflozin treatment for type 2 diabetes mellitus patients with a history of cardiovascular disease
    Leiter, L.
    Cefalu, W.
    DeBruin, T.
    Gause-Nilsson, I.
    Sugg, J.
    Parikh, S.
    [J]. DIABETOLOGIA, 2012, 55 : S310 - S311
  • [33] Quality of ambulatory prevention and treatment of cardiovascular disease and its complications among Type 2 diabetes mellitus patients
    Oganov, R. G.
    Lepakhin, V. K.
    Fitilev, S. B.
    Levin, A. M.
    Shkrebneva, I. I.
    Titarova, Yu. Yu.
    Tsiruleva, Yu. Yu.
    [J]. CARDIOVASCULAR THERAPY AND PREVENTION, 2008, 7 (07): : 9 - 14
  • [34] LIBERALIZATION OF MEDICAL SAVINGS ACCOUNTS FOR OUTPATIENT TREATMENT AND HEALTH CARE UTILIZATION AMONG TYPE 2 DIABETES MELLITUS PATIENTS
    Tan, W. S.
    Ding, Y. Y.
    Wu, C.
    Heng, B. H.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A186 - A186
  • [35] CARDIOVASCULAR OUTCOMES WITH FINERENONE ACCORDING TO STATUS OF GLYCEMIA AT BASELINE AND PRIOR TREATMENT WITH NEWER ANTIDIABETIC REGIMENS AMONG PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Patoulias, Dimitrios
    Papadopoulos, Christodoulos
    Boulmpou, Aristi
    Fragakis, Nikolaos
    Vassilikos, Vassilios P.
    Doumas, Michail
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1532 - 1532
  • [36] Oral antidiabetic medication adherence and health care costs and utilization among medicaid-enrolled type 2 diabetes patients newly starting monotherapy
    Shenolikar, R.
    Balkrishnan, R.
    [J]. VALUE IN HEALTH, 2008, 11 (03) : A21 - A21
  • [37] Association of Geographic Factors with Use of Metabolic Disease Specialty Care among Adults with Type 2 Diabetes and ASCVD
    Bauer, Jessica
    Rothenberger, Scott D.
    Johnson, Amber E.
    Rosland, Ann-Marie
    Kinnee, Ellen
    Zupa, Margaret
    [J]. DIABETES, 2024, 73
  • [38] Prevention of cardiovascular disease in patients with type 2 diabetes
    Lebherz, Corinna
    Lehrke, Michael
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (09) : 645 - U16
  • [39] IMPACT OF MULTIPLE MEDICATION COMPLIANCE ON HEALTH CARE UTILIZATION IN PATIENTS WITH COMORBID TYPE II DIABETES AND CARDIOVASCULAR DISEASE
    Nichol, M. B.
    An, J. J.
    Wu, J.
    Priest, J.
    Knight, T. K.
    Cantrell, C.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A11 - A11
  • [40] The Comparative Cardiovascular Effectiveness of Six Antidiabetic Medications among Insured Adults with Type 2 Diabetes
    O'Brien, Matthew
    Karam, Susan L.
    Wallia, Amisha
    Kang, Raymond
    Cooper, Andrew J.
    Lancki, Nicola
    Moran, Margaret R.
    Liss, David T.
    Prospect, Theodore A.
    Ackermann, Ronald T.
    [J]. DIABETES, 2018, 67
12345